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Introduction
Cancer cervix uteri is globally reported as the second
commonest malignancy affecting women (Jemal et al.,
2002). Worldwide, about 450,000 women are diagnosed
with cervical cancer each year which kills 200,000
annually (Pisani et al., 1999). Almost 80% of these deaths
occur in developing countries, where cervical cancer is
the leading cause of cancer mortality in women (Ghafoor
et al., 2002).
During the two and a half decade period (1973 to 1997)
the incidence rates of cervical cancer decreased in almost
all parts of the developed world. In contrast the incidence
rates for cancer cervix increased in the less-developed
countries and are currently almost two-fold higher in
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Abstract
Introduction: The objective of the study was to determine the trends of cancer cervix in Karachi South
during an eight (1995-2002) year period.  Methodology: Cancer cervix cases recorded at Karachi Cancer Registry
during 1st January 1995 to 31st December 2002 were analyzed. Trends were studied by analyzing the age
standardized incidence rates (ASR)s in 2 time periods, 1995-97 and 1998-2002. Results: Cancer cervix ranked
sixth in the 1995-97 period the age standardized incidence rate (ASR) world and crude incidence rate (CIR) per
100,000 were 6.81 and 3.22.  It reached the fifth ranking in the 1998-2002 period with an ASR and CIR of 7.5
and 4.0 per 100,000. Thus between 1995 and 2002, the incidence of cervical cancer registered an approximate
10% increase. The mean age of the cancer cases was 53.27 years (SD 11.6; 95% CI 50.58, 55.96; range 32-85
years) and 50.68 years (SD 11.7; 95% CI 48.8, 52.5; range 51 years) in period 1 and 2 respectively. The
morphological components of squamous cell carcinoma and adenocarcinoma remained stable during this period,
though a marginally higher component and increasing incidence of adenocarcinoma was observed throughout.
A negligible down staging was observed in the 1998-2002 period. Localized malignancy was observed in 30.8%
in period 2 as compared to 25.7% in period 1 and the component of carcinoma in situ increased from 0%
percent in period 1 to 1.3% in the second period. Despite this two thirds of the cases still presented with a
regional or distant spread of disease.  Conclusion: Pakistan at present falls into a low risk cancer cervix region.
The cause of concern is the steadily increasing incidence especially in the younger birth cohorts, the advanced
disease at presentation; insignificant in-situ cancers and no preventive intervention or awareness practices in
place.
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comparison. The incidence is highest in Africa, India and
Central/South America (approximately 29 per 100,000
person years -PY) and lowest in Oceania, North America
and most Muslim countries (approximately 7.5 per
100,000 PY). Mortality rates also vary more than 10-fold
across continents, therefore the ratio of mortality and
incidence rate (MR:IR) ranges from 0.27 in Oceania to
0.79 in Africa (Kamangar et al., 2006).
Massive Pap screening in the United States was
credited with bringing cervical cancer to number 10 in
the causes of cancer death from being the leading cause
in 1941 (Creasman et al., 1998). Reports from Europe
claim that the introduction of cervical screening programs
to unscreened populations reduced cervical cancer rates
by 60-90% within three years (McCrory et al., 1999).
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When cervical cancer trends in North America and Europe
were correlated significant reductions in the incidence of
invasive cervical cancer and a 20% to 60% reduction in
cervical cancer mortality was reported (McCrory et al.,
1999).
Post 1997 the below 50 years cohort in North America,
Europe and Australia have shown an increasing trend. This
cohort effect could reflect the use of new diagnostic
techniques, such as human papillomavirus (HPV) testing
and cervicography. Another factor potentially affecting
incidence trends is the increase in rates of
adenocarcinomas and adenosquamous carcinomas
(Vizcaino et al., 1998).
The reported incidence of cervical cancer in Karachi
South (1995-97) reflects a low risk population with a late
presentation. The age standardized incidence rate (ASR)
world and crude incidence rate CIR) per 100,000 for
cancer cervix have been reported as 6.81 (5.2, 8.43) and
3.22 (2.49 to 3.96) for the years 1995-97. Cancer cervix
accounted for approximately 3.6% of all cancers in
females and was the sixth commonest malignancy in
women (Bhurgri et al., 2007a;  2007b).
The objective of the study was to determine the time
trends in cancer cervix incidence in Karachi South during
an eight (1995-2002) year period.
Materials and Methods
Epidemiological data of incident cancer cervix cases,
ICD-10 category C53 registered at Karachi Cancer
Registry (KCR) for Karachi South, during 1st January
1995 to 31st December 2002 were reviewed. Trends were
studied by grouping cases into two periods: period 1
(1995-1997) and period 2 (1998-2002). Results for period
1 have been published (Bhurgri Y et al, 2007). Results for
period 2 are given in the section on results.
The study included clinically diagnosed and
microscopically verified cancer cervix cases. All surgical
specimens were initially evaluated on Hematoxylin and
Eosin (H&E) stained sections. Special stains were
selectively used, whenever required. The reported
epidemiological cancer data were rechecked and residency
status re-ascertained. People residing in the specified
geographical regions for more than six months were
considered residents. Demographical variables recorded
were the hospital patient-number, date of incidence, name,
age, sex, address, ethnicity, topography, morphology,
grading and staging (TNM).
The data were classified using ICD-O3 (International
Classification of Diseases-Oncology, 3rd edition) and
computerized using a customized version of CANREG-4
software. This software includes facilities for the detection
of duplicate registrations and for performing internal
checks on the validity of the entered data. Manual and
computerized validity checks for the cancer data were
performed as per recommendations of International
Agency for Research on Cancer (IARC) and International
Association of Cancer Registries (IACR) (Parkin et al.,
1994). This involved factors influencing comparability
i.e. classification and coding.
Crude, age-standardized, and age-specific incidence
rates (CIR, ASR, ASIR) were calculated for cancer cervix.
Incidence tables were based on ICD-10 (WHO, 1992).
The person-years of female population at risk by 5-year
age-groups were estimated with the mid 2000 population,
estimates based on the 1998 census, copy obtained from
the Sindh Bureau of Statistics. The estimated population
of females was 794, 920 assuming an annual growth rate
of 1.94%. The growth rates were based on the inter-census
growth-rate and measures for inflow and outflow of
population, calculated by the Federal Bureau of Statistics.
Standardized incidence rate was calculated with an
external reference population, the ‘world’ population with
a given ‘standard’ age distribution (Segi, 1960). ‘The
standardized rate is the incidence rate that, theoretically,
would have been observed if the population had a standard
age distribution. The methodology applied was direct
standardization, using 5-year age groups. The rates given
are the annual incidence per 100,000 population averaged
over the number of years for which data are presented’.
Data were analyzed using SPSS 16.0.
Results
A total of 233 cases of cancer cervix, ICD-10 category
C53 were registered at the Karachi Cancer Registry, for
Karachi South, during an 8 year period, 1st January 1995
to 31st December 2002. Seventy four cases were recorded
in period 1 (1995-97) and 159 cases in period 2 (1998-
2002). The comparative distribution by age, religion,
ethnicity, education, occupation, marital status and
morphology for both periods is given in Table 1.The age
standardized (ASR) and crude incidence rates (CIR) per
100,000 were 6.81 and 3.22 for period 1; 7.5 and 4.0 per
100,000 for period 2.  Cancer cervix accounted for
approximately 3.6% and 3.9% of all cancers in females
in period 1 and 2 respectively.
In the second period the age-specific incidence curves
(ASIR) showed a gradual increase in from the third up till
the sixth decade, followed by an actual apparent decrease
in risk after 70 years of age (Figure 1). In the first period
the ASIRs had shown an increase from the fourth up till
the sixth decade, followed by an actual apparent decrease
in risk after 70 years of age. The peak incidence was
observed in the 55-59 year age group in both periods.
The majority of the cases presented as moderately
differentiated or grade 2 lesions (72 cases; 45.3%). Well
differentiated (grade 1) and poorly differentiated (grade
3) malignancies contributed 40 (25.2%) and 37 (23.2%)
of the cases respectively. The tumor grade was not known
for 10 (6.3%) cases.
Discussion
 Cancer cervix in the last decade in Karachi South has
remained a malignancy with a low incidence. The cause
of concern is the steadily increasing incidence especially
in the younger birth cohorts, the advanced disease at
presentation, insignificant in-situ cancers, the relatively
high adenocarcinoma and no cancer screening or
awareness practices in place.
Pakistan is one of the few large populated countries
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without any preventive intervention for cancer cervix, thus
the increasing incidence and the late presentation. Most
developed countries in the world currently show a low
incidence of cervical cancer attributed to extensive cancer
Figure 1. Age-standardized Cervix Cancer Incidence
Rates in Karachi South (1995-1997, 1998-2002) in
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Table 1. Frequency of Cancer Cervix Cases with
Reference to Morphology, Religion, Education,
Ethnicity, Marital Status, Occupation & Stage at
Presentation
1995-1997 1998-2002
Age standardized incidence rate 6.8 7.5
Crude incidence rate 3.2 4.0
Relative frequency 3.6 3.9
Mean age (years) 53.3 50.7
Morphology (%)
















Memon Mohajirs 8.1 6.3
Pathans 5.4 10.7
Gujrati speaking Mohajirs 4.1 7.5







Housewives/unskilled workers 97.2 97.5
Professionals 2.8 2.5
Stage (%)
In situ - 1.3
Localized 25.7 30.8
Regional spread 58.1 59.7
Distant disease 8.1 6.3
Unknown 8.1 1.9
screening practices (Kamangar F et al, 2006). Developing
countries in high risk regions and less developed areas in
the developed countries, which had previously shown
alarm, but implemented cervical screening are also
showing a decreasing trend (Yeole BB, 2008; Day GE et
al, 2007).
The age specific curves in Karachi South for both
periods show a developing country pattern with lower rates
in the younger women, a sharp increase after 40 years,
peak between 50-55 years, followed by an apparent
decrease in risk, which can be interpreted as a cohort effect.
Age-specific incidence rates for cancer cervix generally
reveal unique patterns, being higher in younger individuals
in the more-developed countries, but plateau after the age
of 40 years, a phenomenon not seen in the less developed
countries. In contrast the less-developed countries show
lower rates at younger ages which subsequently increase
after age 40 years to exceed those in more-developed
countries. The pattern in the more-developed countries
may in part be attributed to screening practices (Kamangar
F et al, 2006). These effects are apparent in figures 1 where
the Karachi South and SEER white ASIRs are compared.
In Karachi, the highest registered increase in the
incidence of cancer cervix was observed in the younger
age group (<39 years). The rates remained stable in the
older age group (figure 1). The incidence rates in the
younger females are only marginally lower then the rates
of contemporary females in the developed countries like
US. As these are younger birth cohorts, age, this pattern
should translate into a substantial increase in the incidence
and occurrence of cervical cancer in Karachi and probably
Pakistan. In the absence of preventive intervention the
cancer cervix rates in the future may parallel those in the
high risk zones.
Late presentation and advanced disease remain the
hallmark of cancers in Karachi and cancer cervix is no
exception. In both period 1 and 2 approximately two third
the cancers had spread regionally or to a distant site at the
time of diagnosis, indicating that the last decade saw
virtually no cancer cervix awareness in the country. Most
women with cervical cancer in developing countries
present with advanced disease, resulting in low cure rates.
This reflects the poor health structure and the lack of
availability and accessibility of cancer control measures
(Kamangar et al., 2006; Patro and Nongkynrih, 2007).
In the last decade there has been no increase in the in-
situ cancers in Karachi, which remains a grim reality
facing the health providers. In developed countries ever
since the late 1980s there has been an increase in the
incidence rates of carcinoma in situ for women under 30.
For women aged 30-34 there was an increase since 1992,
though there have been no apparent increases for women
over 34 (Quinn et al., 1999; 2001). The pattern of cervical
cancer in Karachi and almost all Muslim countries appears
linked to the comparatively more conservative life-style
pattern and a lesser exposure to risk factors, which has
kept this large block somewhat safe. The cause of alarm
is the increasing incidence in the younger birth cohorts
which may transform this region into a higher risk zone
in the future.
Almost all cervical cancer cases are caused by one of
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